{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:25:03Z","timestamp":1792013103719,"version":"4.4.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To assess associations between subcutaneous neurofibromas (SC-NFs) and internal neurofibromas in patients with neurofibromatosis type 1 (NF-1) and to determine whether the association between SC-NFs and peripheral neuropathy was ascribable to internal neurofibromas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>Prospective multicentre case-control study. Between 2005 and 2008, 110 NF-1 adults having two or more SC-NFs were individually matched for age, sex and hospital with 110 controls who had no SC-NF. Patients underwent standardized MRI of the spinal cord, nerve roots and sciatic nerves and an electrophysiological study. Analyses used adjusted multinomial logistic regression (ORa) to estimate the risk of the presence of internal neurofibromas or peripheral neuropathies associated with patients presented 2 to 9 SC-NFs, at least 10 SC-NFs as compared to patients without any (referential category).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Cases had a mean age of 41 (\u00b1 13) years; 85 (80%) had two to nine SC-NFs and 21 (19%) at least ten SC-NFs. SC-NFs were more strongly associated with internal neurofibromas in patients with ten or more SC-NFs than in patients with fewer NF-SCs (e.g., sciatic nerve, aOR = 29.1 [8.5 to 100] vs. 4.3 [2.1 to 9.0]). The association with SC-NFs was stronger for diffuse, intradural, and &gt; 3 cm internal neurofibromas than with other internal neurofibromas. Axonal neuropathy with slowed conduction velocities (SCV) was more strongly associated with having at least ten SC-NFs (aOR = 29.9, 5.5 to 162.3) than with having fewer SC-NFs (aOR = 4.4, 0.9 to 22.0). Bivariate analyses showed that the association between axonal neuropathy with SCV and sciatic neurofibromas was mediated by the association between SC-NFs and sciatic neurofibromas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The at-risk phenotype of NF-1 patients (i.e. NF-1 patients with SC-NFs) is ascribable to associations linking SC-NFs to internal neurofibromas at risk for malignant transformation and to axonal neuropathies with slowed conduction velocities. Axonal neuropathies with SCV are particularly common in patients with at least ten SC-NFs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Registration details<\/jats:title>\n                    <jats:p>ORPHA86301<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/1750-1172-6-51","type":"journal-article","created":{"date-parts":[[2011,7,14]],"date-time":"2011-07-14T02:16:36Z","timestamp":1310609796000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["At-Risk Phenotype of Neurofibromatose-1 Patients: A Multicentre Case-Control Study"],"prefix":"10.1186","volume":"6","author":[{"given":"Emilie","family":"Sbidian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Bastuji-Garin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Valeyrie-Allanore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah","family":"Ferkal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean P","family":"Lefaucheur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Drouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Brugi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Vialette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Combemale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Barbarot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Wolkenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"NF France Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,13]]},"reference":[{"issue":"5","key":"312_CR1","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1086\/320121","volume":"68","author":"SA Rasmussen","year":"2001","unstructured":"Rasmussen SA, Yang Q, Friedman JM: Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet. 2001, 68 (5): 1110-8. 10.1086\/320121.","journal-title":"Am J Hum Genet"},{"key":"312_CR2","volume-title":"Neurofibromatosis: phenotype, natural history, and pathogenesis","author":"VM Riccardi","year":"1992","unstructured":"Riccardi VM: Neurofibromatosis: phenotype, natural history, and pathogenesis. Johns Hopkins University Press; 1992."},{"issue":"89","key":"312_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<23::AID-AJMG6>3.0.CO;2-#","volume":"26","author":"JM Woodruff","year":"1999","unstructured":"Woodruff JM: Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis. Am J Med Genet. 1999, 26 (89): 23-30.","journal-title":"Am J Med Genet"},{"issue":"2","key":"312_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1001\/archderm.139.2.187","volume":"139","author":"K Khosrotehrani","year":"2003","unstructured":"Khosrotehrani K, Bastuji-Garin S, Zeller J, Revuz J, Wolkenstein P: Clinical risk factors for mortality in patients with neurofibromatosis 1: a cohort study of 378 patients. Arch Dermatol. 2003, 139 (2): 187-91. 10.1001\/archderm.139.2.187.","journal-title":"Arch Dermatol"},{"issue":"1","key":"312_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/ajmg.a.30394","volume":"132A","author":"K Khosrotehrani","year":"2005","unstructured":"Khosrotehrani K, Bastuji-Garin S, Riccardi VM, Birch P, Friedman JM, Wolkenstein P: Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: a cohort study of 703 patients. Am J Med Genet A. 2005, 132A (1): 49-53. 10.1002\/ajmg.a.30394.","journal-title":"Am J Med Genet A"},{"issue":"9","key":"312_CR6","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1038\/jid.2010.100","volume":"130","author":"E Sbidian","year":"2010","unstructured":"Sbidian E, Wolkenstein P, Valeyrie-Allanore L, Rodriguez D, Hadj-Rabia S, Ferkal S, Lacour JP, Leanoard JC, Taillandier L, Sportich S, Berbis P, Bastuji-Garin S: NF-1Score: a prediction score for internal neurofibromas in neurofibromatosis-1. J Invest Dermatol. 2010, 130 (9): 2173-8. 10.1038\/jid.2010.100.","journal-title":"J Invest Dermatol"},{"issue":"Pt 9","key":"312_CR7","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1093\/brain\/awh234","volume":"127","author":"A Drouet","year":"2004","unstructured":"Drouet A, Wolkenstein P, Lefaucheur JP, Pinson S, Combemale P, Gherardi RK: Neurofibromatosis 1-associated neuropathies: a reappraisal. Brain. 2004, 127 (Pt 9): 1993-2009.","journal-title":"Brain"},{"issue":"5","key":"312_CR8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1001\/archneur.1988.00520290115023","volume":"45","author":"Neurofibromatosis.","year":"1988","unstructured":"Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol. 1988, 45 (5): 575-8.","journal-title":"Arch Neurol."},{"key":"312_CR9","doi-asserted-by":"crossref","unstructured":"Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology. 1991, 41: 617-18, Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force.","DOI":"10.1212\/WNL.41.5.617"},{"issue":"1","key":"312_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/oxfordjournals.aje.a010118","volume":"151","author":"SA Rasmussen","year":"2000","unstructured":"Rasmussen SA, Friedman JM: NF1 gene and neurofibromatosis 1. Am J Epidemiol. 2000, 151 (1): 33-40.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"312_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1365-2133.2005.06558.x","volume":"153","author":"L Valeyrie-Allanore","year":"2005","unstructured":"Valeyrie-Allanore L, Ismaili N, Bastuji-Garin S, Zeller J, Wechsler J, Revuz J, Wolkenstein P: Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1. Br J Dermatol. 2005, 153 (1): 79-82. 10.1111\/j.1365-2133.2005.06558.x.","journal-title":"Br J Dermatol"},{"issue":"4","key":"312_CR12","first-page":"567","volume":"128","author":"S Pinson","year":"2001","unstructured":"Pinson S, Creange A, Barbarot S, Stalder JF, Chaix Y, Rodriguez D, Sanson M, Bernheim A, D'incan M, Doz F, Stoll C, Combemale P, Kalifa C, Zeller J, Teillac-Hamel D, Lyonnet S, Zerah M, Jacour JP, Guillot B, Wolkenstein P: Neurofibromatosis 1: recommendations for management. Ann Dermatol Venereol. 2001, 128 (4): 567-75.","journal-title":"Ann Dermatol Venereol"},{"issue":"2","key":"312_CR13","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO;2-U","volume":"70","author":"JM Friedman","year":"1997","unstructured":"Friedman JM, Birch PH: Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. Am J Med Genet. 1997, 70 (2): 138-43. 10.1002\/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO;2-U.","journal-title":"Am J Med Genet"},{"key":"312_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2119\/molmed.2010.00079","volume":"17","author":"EM-PJ Pasmant","year":"2011","unstructured":"Pasmant EM-PJ, L\u00e9vy P, Laurendeau I, Ortonne N, Parfait B, Valeyrie-Allanore L, Leroy K, Wolkenstein P, Vidaud M, Vidaud D, Bi\u00e8che I: Identification of genes potentially involved in the increased risk of malignancy in NF1-microdeleted patients. Mol Med. 2011, 17: 79-87.","journal-title":"Mol Med"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-6-51.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T11:10:28Z","timestamp":1630494628000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/1750-1172-6-51"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,13]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["312"],"URL":"https:\/\/doi.org\/10.1186\/1750-1172-6-51","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,13]]},"assertion":[{"value":"28 April 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"51"}}